PI
CORT icon

PineBridge Investments’s Corcept Therapeutics CORT Stock Holding History

PineBridge Investments’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,378
Closed -$30.7K – 761
2023
Q2 		$30.7K Buy
+1,378
New +$31.7K ﹤0.01% 742
2020
Q1 		– Sell
-57,597
Closed -$697K – 824
2019
Q4 		$697K Sell
57,597
-38,028
-40% -$529K 0.01% 752
2019
Q3 		$1.35M Buy
95,625
+4,714
+5% +$57.9K 0.02% 603
2019
Q2 		$1.01M Buy
90,911
+65,196
+254% +$726K 0.02% 674
2019
Q1 		$302K Sell
25,715
-181
-0.7% -$2.25K 0.01% 788
2018
Q4 		$345K Buy
25,896
+2,537
+11% +$33.5K 0.01% 760
2018
Q3 		$327K Buy
23,359
+6,967
+43% +$97.4K 0.01% 821
2018
Q2 		$258K Sell
16,392
-948
-5% -$16.5K 0.01% 832
2018
Q1 		$285K Buy
+17,340
New +$321K 0.01% 813

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

PineBridge Investments's CORT Position: Q3 2023 in Review

PineBridge Investments sold out of Corcept Therapeutics (CORT) in Q3 2023, closing a stake of 1,378 shares — an estimated $30.7K sold.

PineBridge Investments first reported a position in CORT in Q1 2018 and held it in 9 quarters. The position peaked at $1.35M in Q3 2019. 246 funds tracked by Wall St. Rank hold CORT as of Q3 2023.

  • PineBridge Investments reported no remaining Corcept Therapeutics position as of Q3 2023 after selling out during the quarter.
  • PineBridge Investments sold 1,378 Corcept Therapeutics shares in Q3 2023, an estimated $30.7K.
  • PineBridge Investments first reported a position in Corcept Therapeutics in Q1 2018 and held it in 9 quarters.
  • PineBridge Investments's Corcept Therapeutics position peaked at $1.35M in Q3 2019.
  • 246 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2023.

Based on PineBridge Investments's 13F filing for Q3 2023, filed 14 Nov 2023.